Company

Clinical science, data infrastructure, and company execution.

RetinaTek brings together neurocognitive science, regulated-product strategy, data-platform execution, and company-building experience around objective cognitive measurement.

Chief Science Officer / Inventor

Mark L. Ettenhofer

Co-founder and inventor associated with the foundational cognitively loaded multimodal eye-tracking patent family.

Chief Executive Officer / Business Operations

Ben Bulloch

Leads company-building, commercialization, investor engagement, and operational execution for RetinaTek.

Collaboration model

Built for clinical, research, performance, and strategic partnerships.

RetinaTek works with scientific, clinical, operational, commercialization, rehabilitation, executive-health, and human-performance partners across evidence generation and future platform development.